Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06730646 · ClinicalTrials.gov registry record · NA
Testing Different Anti-smoking Messages Among Chinese Young Adult Smokers and Nonsmokers
A NA study of Smoking Prevention, sponsored by Georgia State University.
- Completed
- Registry status
- NA
- Development phase
- 1,541
- Enrollment target
- 2
- Study locations
NCT06730646: Completed NA study of Smoking Prevention, sponsored by Georgia State University.
NCT06730646 is a NA study of Smoking Prevention that has completed, run by Georgia State University. The registered enrollment target is 1,541 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06730646, a NA study of Smoking Prevention, has completed, sponsored by Georgia State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,541 participants
- Enrollment target
- 2
- Study locations
Study Summary
Young adults are particularly vulnerable to psychological distress during the transition from adolescence to adulthood, making them more susceptible to developing persistent substance use. The tobacco industry capitalizes on this vulnerability by using marketing tactics to promote tobacco initiation and facilitate the progression from experimental tobacco use to long-term use. In China, where the average age of starting daily smoking is 21.1 years old, the number of current young adult smokers exceeds 29 million. It is crucial to develop effective communication messages to counter the tobacco industry's marketing strategies and protect the health of young adults in China. This project aims to test the effects of different anti-smoking message themes among Chinese young adults. In this online randomized clinical trial, participants will be randomly assigned to one of five antismoking message conditions. The investigators will compare the effects of these themes with each other and with the control condition.
Primary Outcome
A five-item scale measuring future intentions to smoke cigarettes and other forms of tobacco over the next year. Response options: from 1 (very unlikely) to 5 (very likely). Higher scores represent stronger intention to use tobacco.
Conditions Studied
Interventions
- BEHAVIORAL Health effects
- BEHAVIORAL Tobacco industry manipulation
- BEHAVIORAL Secondhand smoke
- BEHAVIORAL Mentral health
- BEHAVIORAL Social acceptability
Study Locations (2)
Georgia
- Georgia State university - Atlanta
Shanghai Municipality
- Online - Shanghai
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,541 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2025-10-01 |
| Phase | NA |
What the finished NCT06730646 record still lists
NCT06730646 is an interventional study that assigns participants to a tested intervention. Its 1,541 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% higher).
The record links to 1 condition, with Smoking Prevention appearing as the primary indexed condition, and to 5 interventions - of which Health effects is the first listed.
NCT06730646 reports a single indexed study location in Georgia, Shanghai Municipality.
Frequently Asked Questions
What is clinical trial NCT06730646 about?
NCT06730646 is a clinical study titled "Testing Different Anti-smoking Messages Among Chinese Young Adult Smokers and Nonsmokers". Young adults are particularly vulnerable to psychological distress during the transition from adolescence to adulthood, making them more susceptible to developing persistent substance use. The tobacco industry capitalizes on this vulnerability by using marketing tactics to promote tobacco initiation...
What is the current status of trial NCT06730646?
This trial is currently completed. It is a NA study. The enrollment target is 1,541 participants. The study started on 2025-09-01. Estimated completion is 2025-10-01.
What conditions does trial NCT06730646 study?
This clinical trial studies the following conditions: Smoking Prevention.
What interventions are being tested in trial NCT06730646?
The interventions under investigation include: Health effects (BEHAVIORAL), Tobacco industry manipulation (BEHAVIORAL), Secondhand smoke (BEHAVIORAL), Mentral health (BEHAVIORAL), Social acceptability (BEHAVIORAL).
Who is sponsoring clinical trial NCT06730646?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06730646 being conducted?
This trial has 2 study locations across Georgia, Shanghai Municipality. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06730646's enrollment target sits among peer trials
1,541 65th of 2000 higher than 1,936 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT06842875 · 1,536 participants · NA
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI